X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (46601) 46601
Newspaper Article (9968) 9968
Newsletter (2245) 2245
Magazine Article (650) 650
Book Chapter (298) 298
Trade Publication Article (177) 177
Web Resource (137) 137
Book / eBook (119) 119
Conference Proceeding (68) 68
Dissertation (49) 49
Transcript (45) 45
Book Review (40) 40
Government Document (33) 33
Reference (28) 28
Publication (17) 17
Streaming Video (8) 8
Report (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31788) 31788
parkinson's disease (25297) 25297
male (17923) 17923
parkinson disease - drug therapy (16024) 16024
parkinsons disease (15879) 15879
female (14639) 14639
neurosciences (13838) 13838
clinical neurology (12257) 12257
animals (12210) 12210
middle aged (12079) 12079
aged (11936) 11936
parkinsons-disease (10691) 10691
dopamine (7218) 7218
neurology (6677) 6677
parkinson disease - physiopathology (5766) 5766
adult (5530) 5530
levodopa - therapeutic use (5475) 5475
movement disorders (5420) 5420
neurodegenerative diseases (5406) 5406
parkinson’s disease (5310) 5310
antiparkinson agents - therapeutic use (5204) 5204
pharmacology & pharmacy (4839) 4839
research (4806) 4806
medical research (4802) 4802
rats (4399) 4399
parkinson disease - complications (4154) 4154
brain (4087) 4087
levodopa (3942) 3942
drug therapy (3911) 3911
analysis (3745) 3745
medicine, experimental (3735) 3735
psychiatry (3666) 3666
neurons (3635) 3635
nervous system (3570) 3570
clinical trials (3541) 3541
care and treatment (3417) 3417
oxidative stress (3351) 3351
neurodegeneration (3348) 3348
disease models, animal (3345) 3345
mice (3189) 3189
parkinson disease - therapy (3154) 3154
dementia (3142) 3142
alzheimers-disease (3032) 3032
parkinson disease - metabolism (3014) 3014
treatment outcome (2934) 2934
alzheimers disease (2892) 2892
levodopa - adverse effects (2834) 2834
basal ganglia (2790) 2790
aged, 80 and over (2773) 2773
parkinson disease (2747) 2747
patients (2687) 2687
dopamine - metabolism (2674) 2674
alzheimer's disease (2660) 2660
proteins (2631) 2631
antiparkinson agents - adverse effects (2630) 2630
studies (2599) 2599
pharmaceutical industry (2557) 2557
nervous system diseases (2532) 2532
drugs (2465) 2465
biochemistry & molecular biology (2377) 2377
health aspects (2344) 2344
disease (2331) 2331
risk factors (2255) 2255
neuroprotection (2231) 2231
time factors (2217) 2217
dose-response relationship, drug (2205) 2205
parkinson disease - diagnosis (2180) 2180
alpha-synuclein (2178) 2178
medicine & public health (2172) 2172
parkinson disease - pathology (2099) 2099
medicine (2084) 2084
double-blind (2045) 2045
cell biology (2013) 2013
substantia-nigra (2012) 2012
levodopa - administration & dosage (2005) 2005
dopa (1963) 1963
parkinson disease - psychology (1963) 1963
diagnosis (1949) 1949
deep brain stimulation (1871) 1871
severity of illness index (1846) 1846
rats, sprague-dawley (1802) 1802
stem cells (1799) 1799
apoptosis (1798) 1798
brain research (1793) 1793
surgery (1767) 1767
l-dopa (1756) 1756
review (1726) 1726
quality of life (1709) 1709
drug therapy, combination (1683) 1683
therapy (1664) 1664
antiparkinson agents - administration & dosage (1629) 1629
physiological aspects (1623) 1623
neuroprotective agents - pharmacology (1622) 1622
research article (1610) 1610
subthalamic nucleus (1584) 1584
brain - metabolism (1574) 1574
antiparkinsonian agents (1558) 1558
depression (1508) 1508
biomedicine (1496) 1496
rodents (1490) 1490
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (72) 72
Online Resources - Online (22) 22
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Baycrest Hospital - Stacks (6) 6
Baycrest Hospital - Wellness Library (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Credit Valley Hospital - Online (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Trillium Health Centre - Reserve desk (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (57744) 57744
German (740) 740
French (577) 577
Spanish (407) 407
Japanese (405) 405
Russian (318) 318
Italian (208) 208
Polish (135) 135
Chinese (109) 109
Portuguese (101) 101
Dutch (76) 76
Swedish (50) 50
Norwegian (49) 49
Hungarian (45) 45
Danish (37) 37
Finnish (26) 26
Czech (21) 21
Turkish (18) 18
Serbian (15) 15
Hebrew (14) 14
Romanian (11) 11
Croatian (6) 6
Korean (4) 4
Arabic (2) 2
Slovak (2) 2
Slovenian (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Icelandic (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of controlled release, ISSN 0168-3659, 2015, Volume 207, pp. 18 - 30
Exosomes are naturally occurring nanosized vesicles that have attracted considerable attention as drug delivery vehicles in the past few years... 
Oxidative stress | Neuroinflammation | Parkinson's disease | Catalase | Exosomes | Blood–brain barrier | Blood-brain barrier | ALZHEIMERS-DISEASE | REPEATED INJECTIONS | MACROPHAGE DELIVERY | MEDIATED TRANSFER | BLOOD-BRAIN-BARRIER | BIOLOGICAL BARRIERS | CHEMISTRY, MULTIDISCIPLINARY | IN-VITRO | PEGYLATED LIPOSOMES | PHARMACOLOGY & PHARMACY | SUPEROXIDE-DISMUTASE | Antioxidants - chemistry | Antioxidants - metabolism | Oxidopamine | Anti-Inflammatory Agents - metabolism | PC12 Cells | Neuroprotective Agents - metabolism | Drug Carriers | Brain - metabolism | Nanoparticles | Parkinsonian Disorders - metabolism | Parkinsonian Disorders - drug therapy | Antiparkinson Agents - chemistry | Anti-Inflammatory Agents - administration & dosage | Female | Neurons - metabolism | Neuroprotective Agents - administration & dosage | Nanomedicine | Disease Models, Animal | Neuroprotective Agents - chemistry | Mice, Inbred C57BL | Solubility | Rats | Technology, Pharmaceutical - methods | Parkinsonian Disorders - chemically induced | Administration, Intranasal | Chemistry, Pharmaceutical | Brain - drug effects | Catalase - metabolism | Catalase - administration & dosage | Animals | Anti-Inflammatory Agents - chemistry | Antioxidants - administration & dosage | RAW 264.7 Cells | Antiparkinson Agents - administration & dosage | Mice | Kinetics | Oxidative Stress - drug effects | Antiparkinson Agents - metabolism | Catalase - chemistry | Drugs | Drug delivery systems | Proteases | Analysis | Antiparkinsonian agents | Vehicles | blood-brain barrier | neuroinflammation | exosomes | catalase | oxidative stress | Parkinson’s disease
Journal Article
Trends in Neurosciences, ISSN 0166-2236, 2009, Volume 32, Issue 11, pp. 591 - 601
.... Treatment with various HDAC inhibitors can correct these deficiencies and has emerged as a promising new strategy for therapeutic intervention in neurodegenerative disease... 
Neurology | SPINAL MUSCULAR-ATROPHY | SUBEROYLANILIDE HYDROXAMIC ACID | PROTECTS DOPAMINERGIC-NEURONS | INCREASES SMN EXPRESSION | VALPROIC ACID | HISTONE DEACETYLASE INHIBITORS | BDNF GENE-TRANSCRIPTION | TRANSGENIC MOUSE MODEL | HUNTINGTONS-DISEASE | NEUROSCIENCES | HEAT-SHOCK-PROTEIN | Neuroprotective Agents - therapeutic use | Amyotrophic Lateral Sclerosis - physiopathology | Humans | Muscular Atrophy, Spinal - enzymology | Parkinson Disease - drug therapy | Neurodegenerative Diseases - drug therapy | Stroke - physiopathology | Amyotrophic Lateral Sclerosis - drug therapy | Amyotrophic Lateral Sclerosis - enzymology | Acetylation | Huntington Disease - drug therapy | Huntington Disease - enzymology | Muscular Atrophy, Spinal - physiopathology | Huntington Disease - physiopathology | Disease Models, Animal | Alzheimer Disease - physiopathology | Neurodegenerative Diseases - pathology | Alzheimer Disease - drug therapy | Rats | Histone Deacetylases - metabolism | Stroke - drug therapy | Alzheimer Disease - enzymology | Parkinson Disease - physiopathology | Stroke - enzymology | Animals | Neurodegenerative Diseases - physiopathology | Neuroprotective Agents - classification | Parkinson Disease - enzymology | Muscular Atrophy, Spinal - drug therapy | Histone Deacetylase Inhibitors - therapeutic use | Histones - metabolism | Neurodegenerative Diseases - enzymology | Histones | Nervous system diseases | Analysis
Journal Article
Experimental & molecular medicine, ISSN 2092-6413, 2015, Volume 47, Issue 3, pp. e147 - e147
Mammalian cells remove misfolded proteins using various proteolytic systems, including the ubiquitin (Ub)-proteasome system (UPS), chaperone mediated autophagy... 
MEDICINE, RESEARCH & EXPERIMENTAL | UBIQUITIN-PROTEASOME SYSTEM | CHAPERONE-MEDIATED AUTOPHAGY | ALPHA-SYNUCLEIN AGGREGATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | QUALITY CONTROL DEGRADATION | CENTRAL-NERVOUS-SYSTEM | AMYOTROPHIC-LATERAL-SCLEROSIS | SOD1 TRANSGENIC MICE | ENDOPLASMIC-RETICULUM STRESS | END RULE PATHWAY | PARKINSONS-DISEASE | Proteostasis Deficiencies - metabolism | Humans | Ubiquitin - metabolism | tau Proteins - metabolism | Parkinson Disease - drug therapy | Molecular Targeted Therapy | Neurodegenerative Diseases - drug therapy | Amyotrophic Lateral Sclerosis - drug therapy | Autophagy - drug effects | DNA-Binding Proteins - metabolism | PrPSc Proteins - metabolism | Lysosomes - metabolism | Proteolysis | Amyloid beta-Peptides - metabolism | Parkinson Disease - metabolism | Huntington Disease - drug therapy | Superoxide Dismutase - metabolism | Prion Diseases - drug therapy | Alzheimer Disease - drug therapy | Neurodegenerative Diseases - metabolism | Huntington Disease - metabolism | Nerve Tissue Proteins - genetics | Nerve Tissue Proteins - metabolism | Huntingtin Protein | Animals | Alzheimer Disease - metabolism | Amyotrophic Lateral Sclerosis - metabolism | Huntington Disease - genetics | Mutation | Proteasome Endopeptidase Complex - metabolism | alpha-Synuclein - metabolism | Prion Diseases - metabolism | Review
Journal Article
Movement disorders, ISSN 0885-3185, 2011, Volume 26, Issue S3, pp. S42 - S80
Journal Article